Intellia Therapeutics, Inc. - NTLA

SEC FilingsOur NTLA Tweets

About Gravity Analytica

Recent News

  • 09.23.2025 - Bernstein Healthcare Forum
  • 09.04.2025 - Wells Fargo Health Care Conference
  • 08.07.2025 - Intellia Therapeutics Second Quarter 2025 Earnings Conference Call
  • 08.07.2025 - Intellia Therapeutics Second Quarter 2025 Earnings Conference Call
  • 08.07.2025 - Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
  • 08.07.2025 - Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
  • 08.01.2025 - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • 08.01.2025 - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • 07.31.2025 - Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
  • 07.31.2025 - Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates

Recent Filings

  • 08.07.2025 - EX-99.1 EX-99.1
  • 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.07.2025 - 8-K Current report
  • 07.25.2025 - 4 Statement of changes in beneficial ownership of securities
  • 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 07.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.18.2025 - 4 Statement of changes in beneficial ownership of securities